A. E. Doyle

3.4k total citations
100 papers, 2.5k citations indexed

About

A. E. Doyle is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, A. E. Doyle has authored 100 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Physiology. Recurrent topics in A. E. Doyle's work include Blood Pressure and Hypertension Studies (21 papers), Hormonal Regulation and Hypertension (15 papers) and Renin-Angiotensin System Studies (14 papers). A. E. Doyle is often cited by papers focused on Blood Pressure and Hypertension Studies (21 papers), Hormonal Regulation and Hypertension (15 papers) and Renin-Angiotensin System Studies (14 papers). A. E. Doyle collaborates with scholars based in Australia, United Kingdom and United States. A. E. Doyle's co-authors include S. N. Anavekar, William J. Louis, Stephen Harrap, F. A. O. Mendelsohn, George Jerums, J. S. Hutchinson, Terri J. Allen, W. J. Louis, Richard O’Brien and Mark E. Cooper and has published in prestigious journals such as New England Journal of Medicine, Circulation and Circulation Research.

In The Last Decade

A. E. Doyle

94 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Doyle Australia 29 1.3k 652 418 358 348 100 2.5k
C Beretta-Piccoli Switzerland 26 1.1k 0.9× 854 1.3× 328 0.8× 390 1.1× 421 1.2× 108 2.2k
Minoru Yasujima Japan 25 973 0.7× 627 1.0× 575 1.4× 579 1.6× 219 0.6× 197 2.7k
E D Frohlich United States 27 1.5k 1.1× 411 0.6× 330 0.8× 499 1.4× 194 0.6× 63 2.4k
Ivar Eide Norway 29 1.3k 1.0× 624 1.0× 270 0.6× 486 1.4× 246 0.7× 144 2.8k
Clive Rosendorff United States 29 1.8k 1.4× 625 1.0× 551 1.3× 734 2.1× 212 0.6× 167 3.9k
Gordon S. Stokes Australia 26 805 0.6× 422 0.6× 473 1.1× 283 0.8× 146 0.4× 130 2.0k
J Sassard France 29 1.5k 1.1× 885 1.4× 764 1.8× 779 2.2× 163 0.5× 220 3.3k
P. van Brummelen Netherlands 36 1.5k 1.1× 704 1.1× 692 1.7× 441 1.2× 165 0.5× 136 3.9k
Leslie Baer United States 22 1.5k 1.2× 1.3k 2.0× 511 1.2× 238 0.7× 268 0.8× 34 3.4k
James J. Morton United Kingdom 30 1.4k 1.1× 673 1.0× 474 1.1× 692 1.9× 172 0.5× 62 3.0k

Countries citing papers authored by A. E. Doyle

Since Specialization
Citations

This map shows the geographic impact of A. E. Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Doyle more than expected).

Fields of papers citing papers by A. E. Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Doyle. The network helps show where A. E. Doyle may publish in the future.

Co-authorship network of co-authors of A. E. Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Doyle. A scholar is included among the top collaborators of A. E. Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Doyle. A. E. Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garrison, Aaron P., et al.. (2025). Tuberculosis Reactivation Following Plasmapheresis and Perioperative Intravenous Immunoglobulin for Heparin-Induced Thrombocytopenia and Mechanical Mitral Valve Replacement. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7891–A7891.
2.
Doyle, A. E., Mairi Cowan, Hervé Migaud, P.J. Wright, & Andrew Davie. (2021). Neuroendocrine regulation of reproduction in Atlantic cod (Gadus morhua): Evidence of Eya3 as an integrator of photoperiodic cues and nutritional regulation to initiate sexual maturation. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 260. 111000–111000. 9 indexed citations
3.
Hucklebridge, Frank, et al.. (1998). Regional and molecular separation of the four bioactivities of `tribulin'. Neuroscience Letters. 240(1). 29–32. 4 indexed citations
4.
Doyle, A. E., Frank Hucklebridge, Phil Evans, & Angela Clow. (1996). Urinary output of endogenous monoamine oxidase inhibitory activity is related to everyday stress. Life Sciences. 58(20). 1723–1730. 14 indexed citations
5.
Doyle, A. E.. (1993). A Review of the Short-Term Benefits of Antihypertensive Treatment With Emphasis on Stroke. American Journal of Hypertension. 6(3_Pt_2). 6S–8S. 3 indexed citations
6.
Cooper, M. E., et al.. (1992). Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney International. 41(4). 898–903. 45 indexed citations
7.
Cooper, Mark E. & A. E. Doyle. (1992). The Management of Diabetic Proteinuria. Drugs & Aging. 2(4). 301–309. 5 indexed citations
9.
Doyle, A. E.. (1991). Hypertension and Vascular Disease. American Journal of Hypertension. 4(2_Pt_2). 103S–106S. 60 indexed citations
10.
Doyle, A. E.. (1991). Age-Related Effects of 5-HT2 Antagonists. Journal of Cardiovascular Pharmacology. 17(Supplement 5). S35–S35. 5 indexed citations
11.
Doyle, A. E.. (1990). Serotonin antagonists and vascular protection. Cardiovascular Drugs and Therapy. 4(1). 13–18. 9 indexed citations
12.
Zanchetti, Alberto, John Chalmers, Pierre Corvol, et al.. (1989). 1989 Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. Bulletin of the World Health Organization. 67(5). 493–498. 57 indexed citations
13.
Cooper, Mark E., Terri J. Allen, Richard O’Brien, et al.. (1988). Effects of genetic hypertension on diabetic nephropathy in the rat ??? functional and structural characteristics. Journal of Hypertension. 6(12). 1009–1016. 87 indexed citations
14.
Doyle, A. E. & Colin I. Johnston. (1988). AUSTRALASIAN CONTRIBUTIONS TO RESEARCH INTO HYPERTENSION. Australian and New Zealand Journal of Medicine. 18(3). 245–249. 1 indexed citations
15.
Doyle, A. E.. (1987). The Australian Therapeutic Trial in Mild Hypertension. ˜The œNephron journals/Nephron journals. 47(1). 115–119. 190 indexed citations
16.
Doyle, A. E.. (1984). Clinical pharmacology of antihypertensive drugs. Elsevier eBooks. 2 indexed citations
17.
Doyle, A. E. & Alexander G. Bearn. (1984). Hypertension and the Angiotensin System: Therapeutic Approaches. Medical Entomology and Zoology. 19 indexed citations
18.
Doyle, A. E.. (1984). Exchangeable Sodium in Renal Hypertension in the Rat. Journal of Cardiovascular Pharmacology. 6. S115–S115. 1 indexed citations
19.
Dickens, Paul, Gregory J. Dusting, A. E. Doyle, & T. John Martin. (1982). METABOLISM OF ARACHIDONIC ACID IN THE AORTA OF SPONTANEOUSLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 9(3). 253–257. 8 indexed citations
20.
Anavekar, S. N., et al.. (1979). Evaluation of Indapamide in the Treatment of Hypertension. Journal of Cardiovascular Pharmacology. 1(4). 389–394. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026